InvestorsHub Logo
Followers 0
Posts 436
Boards Moderated 0
Alias Born 11/06/2013

Re: None

Thursday, 01/12/2017 10:07:29 AM

Thursday, January 12, 2017 10:07:29 AM

Post# of 77152
EAPH has proven products which Bayer are currently selling in all of Europe and Brazil. Bayer paid a lot of money for Brazil. Mexico's market is considered more valuable because EAPH already HAS regulatory approval. So if anyone asks why would Bayer or Gideon get involved with EAPH, you now have the answer. EAPH is undervalued at this price. Sales have started with Gideon so again, EAPH is undervalued with what they have secured right now and not with what they could secure.